Literature DB >> 22687923

NMR-based metabolomic analysis of human bladder cancer.

Ming Cao1, Liangcai Zhao, Haige Chen, Wei Xue, Donghai Lin.   

Abstract

Bladder cancer (BC) is one of the most common cancers and has a high mortality rate. However, both metabolite variations and metabolic pathways related to the pathogenic process of BC remain to be addressed, such results might contribute to early detection of the disease. (1)H nuclear magnetic resonance (NMR)-based metabolomics was applied to identify differences of serum metabolic profiles among BC, calculi patients and healthy subjects. Serum metabolic profiles of BC patients are distinctly different from those of calculi and healthy subjects. Compared with those from healthy subjects, serum samples from BC patients show decreased levels of isoleucine/leucine, tyrosine, lactate, glycine, citrate, as well as increased levels of lipids and glucose. The results reveal disturbed metabolic pathways of aromatic amino acids, glycolysis and citrate cycle, as well as lipogenesis metabolism in BC patients. Our work will be of potential benefit to understanding the pathogenic process of BC and will offer valuable information for noninvasive diagnosis of the disease.

Entities:  

Mesh:

Year:  2012        PMID: 22687923     DOI: 10.2116/analsci.28.451

Source DB:  PubMed          Journal:  Anal Sci        ISSN: 0910-6340            Impact factor:   2.081


  23 in total

1.  Recognition of early and late stages of bladder cancer using metabolites and machine learning.

Authors:  Valentina L Kouznetsova; Elliot Kim; Eden L Romm; Alan Zhu; Igor F Tsigelny
Journal:  Metabolomics       Date:  2019-06-20       Impact factor: 4.290

Review 2.  Recent advances in the metabolomic study of bladder cancer.

Authors:  Chandra Sekhar Amara; Venkatrao Vantaku; Yair Lotan; Nagireddy Putluri
Journal:  Expert Rev Proteomics       Date:  2019-02-26       Impact factor: 3.940

3.  Metabolomics in bladder cancer: a systematic review.

Authors:  Yidong Cheng; Xiao Yang; Xiaheng Deng; Xiaolei Zhang; Pengchao Li; Jun Tao; Chao Qin; Jifu Wei; Qiang Lu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 4.  Potential role of metabolomics in diagnosis and surveillance of gastric cancer.

Authors:  Angela W Chan; Richdeep S Gill; Daniel Schiller; Michael B Sawyer
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

5.  NMR Metabolomics Analysis of Parkinson's Disease.

Authors:  Shulei Lei; Robert Powers
Journal:  Curr Metabolomics       Date:  2013

6.  Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival.

Authors:  Venkatrao Vantaku; Sri Ramya Donepudi; Danthasinghe Waduge Badrajee Piyarathna; Chandra Sekhar Amara; Chandrashekar R Ambati; Wei Tang; Vasanta Putluri; Darshan S Chandrashekar; Sooryanarayana Varambally; Martha K Terris; Kimberly Davies; Stefan Ambs; Roni Bollag; Andrea B Apolo; Arun Sreekumar; Nagireddy Putluri
Journal:  Cancer       Date:  2019-01-02       Impact factor: 6.860

7.  Serum Metabolic Profiling Identified a Distinct Metabolic Signature in Bladder Cancer Smokers: A Key Metabolic Enzyme Associated with Patient Survival.

Authors:  Chandra Sekhar Amara; Chandrashekar R Ambati; Venkatrao Vantaku; Danthasinghe Waduge Badrajee Piyarathna; Sri Ramya Donepudi; Shiva Shankar Ravi; James M Arnold; Vasanta Putluri; Gurkamal Chatta; Khurshid A Guru; Hoda Badr; Martha K Terris; Roni J Bollag; Arun Sreekumar; Andrea B Apolo; Nagireddy Putluri
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-14       Impact factor: 4.254

8.  Serum metabolomic analysis of human upper urinary tract urothelial carcinoma.

Authors:  Pengchao Li; Jun Tao; Dandan Wei; Xiao Yang; Zhaoguang Lu; Xiaheng Deng; Yiong Cheng; Jinbao Gu; Xuejian Yang; Zengjun Wang; Qiang Lu; Junsong Wang; Changjun Yin
Journal:  Tumour Biol       Date:  2015-04-28

9.  HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease.

Authors:  Pratima Tripathi; Bagganahalli S Somashekar; M Ponnusamy; Amy Gursky; Stephen Dailey; Priya Kunju; Cheryl T Lee; Arul M Chinnaiyan; Thekkelnaycke M Rajendiran; Ayyalusamy Ramamoorthy
Journal:  J Proteome Res       Date:  2013-06-18       Impact factor: 4.466

Review 10.  Review: toxicometabolomics.

Authors:  Mounir Bouhifd; Thomas Hartung; Helena T Hogberg; Andre Kleensang; Liang Zhao
Journal:  J Appl Toxicol       Date:  2013-05-30       Impact factor: 3.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.